Dermata Therapeutics Inc. Skyrocketed
Dermata Therapeutics Inc. (DRMA:NASDAQ) shot up at $2.53, a gain of 60.1%. On Tue, Apr 18, 2023, DRMA:NASDAQ touched a New 2-Week High of $2.53. The stock got featured on our News Catalysts scanner on Mon, Mar 20, 2023 at 06:43 PM in the 'PUBLIC OFFERING' category. From Tue, Apr 04, 2023, the stock recorded 44.44% Up Days and 30.00% Green Days
The stock spiked on Tue, Apr 18, 2023 at $3.91 with a volume of 69M+.
About Dermata Therapeutics Inc. (DRMA:NASDAQ)
Dermata Therapeutics Inc is a clinical-stage biotechnology company. It is focused on the treatment of multiple medical and aesthetic skin conditions and diseases with high unmet needs.
Top 10 Gainers:
- BELLUS Health Inc. (BLU:NASDAQ), 98.9%
- Agrify Corporation (AGFY:NASDAQ), 73.91%
- Oblong Inc. (OBLG:NASDAQ), 61.21%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 60.13%
- Super League Gaming, Inc. (SLGG:NASDAQ), 54.44%
- Gamida Cell Ltd. (GMDA:NASDAQ), 50.89%
- Glory Star New Media Group Holdings Limited (GSMG:NASDAQ), 47.92%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 44.98%
- Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 42.49%
- SAB Biotherapeutics Inc. (SABS:NASDAQ), 41.56%